Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007

Search Blogs that Mention this News Release
Click this link to view linked Bookmarking Services
Click this link to view linked Blogging Services
Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
    RIO DE JANEIRO, Brazil, March 11 /PRNewswire-FirstCall/ -- Amilpar
(BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and Reuters: AMIL3.SA), the largest
managed care organization in Brazil, announced today its consolidated
results for the fourth quarter 2007 and full year of 2007. The Company's
operational and financial information is presented on a consolidated basis
and in Brazilian Reais, in accordance with Brazilian Corporate Law and the
Accounts Chart of the Agencia Nacional de Saude - ANS (Brazil's National
Health Agency).


    To access the complete Press Release, access the Company's IR website.

    2007 Highlights
    -- Total membership stood at over 2.69 million at the end of December, a
       34.0% increase compared to 2006.

    -- Adjusted Operating Revenues totaled R$ 3,465.7 million, 32.2% more than
       in 2006.

    -- Adjusted EBITDA amounted to R$ 382.8 million, an increase of 101.0%
       over 2006, accompanied by an adjusted EBITDA margin of 11.0%, up by 3.8
       p.p.

    -- The Medical Loss Ratio came to 68.1%, around 3.6 p.p. down from 2006.

    -- The Company posted an annual adjusted Net Income of R$ 281.3 million,
       excluding non-recurring items, a figure 115.7% higher than in 2006.


    Conference Calls
    English
    March 12, 2008
    12:00 (11:00 New York)
    Phone: +1 (973) 935-8893
    Code: 34933715

    Portuguese
    March 12, 2008
    15:00 (14:00 New York)
    Phone: +55 (11) 2188-0188
    Code: Amil



                             2007     2006             4T07     4T06
    HIGHLIGHTS             Audited  Proforma  Var.   Audited  Proforma  Var.
    Total Number of
     Members               2,689.3  2,007.1   34.0%  2,689.3  2,007.1   34.0%
    Adjusted Operating
     Revenue* (R$ million) 3,465.7  2,621.0   32.2%    953.9    701.0   36.1%

    EBITDA* (R$ million)     382.8    190.4  101.0%    114.5     61.5   86.1%
    EBITDA Margin* (%)       11.0%     7.2%  3.8p.p.   12.0%     8.8%  3.2p.p.
    Medical Loss Ratio*(%)   68.1%    71.7% -3.6p.p.   67.6%    69.6% -2.0p.p.
    Net Income* (R$ million) 281.3    130.4  115.7%    105.8     26.7  296.3%
    Earnings per Share*       0.78     0.36  115.7%     0.29     0.07  296.3%

    * Excluding non-recurring items



    SHARE DETAILS
    Our shares are traded on the Novo Mercado under the ticker AMIL3.

    Total no. of Shares                360,422,900
    Price on 12/31/07                     R$ 16.30

    Average daily traded volume     R$ 6.9 million
    Market Cap on 12/31/07          R$ 5.9 billion
SOURCE Amilpar
http://www.amilpar.com.br/ir
CONTACT:
Erwin Kleuser, Investor Relations Officer,
+55-21-3805-1155, invest@amil.com.br